The frequency of CD14−/low/CD16+/TIM-3+ monocytes was increased in PBMC of fast progressing patients with ALS compared with slowly progressing patients (#p < 0.001) and HC (p < 0.001) (Fig. 3G). This evidence concerns the gene CD14 and amyotrophic lateral sclerosis.